Allergic rhinitis in children and adults - international recommendations adapted to the clinical situation in Sweden

Allergic rhinitis is the most common chronic disease in Sweden, with impact on quality of life and with a heavy economic burden for the society. More than 20 years have passed since national recommendations were launched, and meanwhile both ARIA (Allergic rhinitis and its impact of asthma) and EUFOREA (The European Forum for Research and Education in Allergy and Airway Diseases) have presented international guidelines which in this article have been adapted to the clinical situation in Sweden. Visual analogue scale (VAS) is recommended for symptom evaluation, and the importance of correct allergen analysis and examination for coexisting asthma is emphasized. Treatment is recommended according to EUFOREA. Follow-up is important, and if VAS is ≥5 the disease is regarded as uncontrolled and must lead to a change of treatment. Since self-treatment is common in allergic rhinitis the importance of patient cooperation and information is underlined.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:120

Enthalten in:

Lakartidningen - 120(2023) vom: 09. Juni

Sprache:

Schwedisch

Weiterer Titel:

Allergisk rinit hos barn och vuxna

Beteiligte Personen:

Holmström, Mats [VerfasserIn]
Davidsson, Åke [VerfasserIn]
Stridh, Björn [VerfasserIn]
Melén, Erik [VerfasserIn]
Westman, Marit [VerfasserIn]
Brunkhorst, Adrian [VerfasserIn]
Nyström, Ulla [VerfasserIn]

Themen:

English Abstract
Journal Article

Anmerkungen:

Date Completed 12.06.2023

Date Revised 08.12.2023

published: Electronic

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM357955285